These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 33541851)

  • 21. Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality.
    Rama TA; Torrado I; Henriques AF; Sánchez-Muñoz L; Jara-Acevedo M; Navarro-Navarro P; Caldas C; Mayado A; Muñoz-González J; García-Montero A; Mollejo M; Redondo E; Garbán A; Moreira A; Órfão A; Álvarez-Twose I
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):908-919.e4. PubMed ID: 36535520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversible Elevation of Tryptase Over the Individual's Baseline: Why is It the Best Biomarker for Severe Systemic Mast Cell Activation and MCAS?
    Valent P; Akin C; Arock M
    Curr Allergy Asthma Rep; 2024 Mar; 24(3):133-141. PubMed ID: 38308674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome.
    Valent P; Akin C; Bonadonna P; Hartmann K; Brockow K; Niedoszytko M; Nedoszytko B; Siebenhaar F; Sperr WR; Oude Elberink JNG; Butterfield JH; Alvarez-Twose I; Sotlar K; Reiter A; Kluin-Nelemans HC; Hermine O; Gotlib J; Broesby-Olsen S; Orfao A; Horny HP; Triggiani M; Arock M; Schwartz LB; Metcalfe DD
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1125-1133.e1. PubMed ID: 30737190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell-Mediated Reactions.
    Shin H; Lyons JJ
    Curr Allergy Asthma Rep; 2024 Apr; 24(4):199-209. PubMed ID: 38460022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to diagnose mast cell activation syndrome: practical considerations.
    Romantowski J; Górska A; Lange M; Nedoszytko B; Gruchała-Niedoszytko M; Niedoszytko M
    Pol Arch Intern Med; 2020 Apr; 130(4):317-323. PubMed ID: 32096778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mast cell activation syndromes: definition and classification.
    Valent P
    Allergy; 2013 Apr; 68(4):417-24. PubMed ID: 23409940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology.
    Giannetti MP; Akin C; Hufdhi R; Hamilton MJ; Weller E; van Anrooij B; Lyons JJ; Hornick JL; Pinkus G; Castells M; Pozdnyakova O
    J Allergy Clin Immunol; 2021 Apr; 147(4):1497-1501.e1. PubMed ID: 33248113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The presence of mast cell clonality in patients with unexplained anaphylaxis.
    Gülen T; Hägglund H; Sander B; Dahlén B; Nilsson G
    Clin Exp Allergy; 2014 Sep; 44(9):1179-87. PubMed ID: 25039926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient characteristics of suspected mast-cell activation syndrome with sinonasal obstruction: a single institution experience.
    Kim JH; Xi S; Ference EH; Ge M; Liu MM; Wrobel BB
    Int Forum Allergy Rhinol; 2020 Aug; 10(8):996-1000. PubMed ID: 32407593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of Clonality and Underlying Mastocytosis in Mast Cell Activation Syndromes.
    Gonzalez-de-Olano D; Álvarez-Twose I
    Curr Allergy Asthma Rep; 2024 Feb; 24(2):25-32. PubMed ID: 38270805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis.
    Gulen T
    Immunol Allergy Clin North Am; 2023 Nov; 43(4):681-698. PubMed ID: 37758406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.
    Valent P; Akin C; Arock M; Brockow K; Butterfield JH; Carter MC; Castells M; Escribano L; Hartmann K; Lieberman P; Nedoszytko B; Orfao A; Schwartz LB; Sotlar K; Sperr WR; Triggiani M; Valenta R; Horny HP; Metcalfe DD
    Int Arch Allergy Immunol; 2012; 157(3):215-25. PubMed ID: 22041891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic value of tryptase in anaphylaxis and mastocytosis.
    Schwartz LB
    Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease Spectrum of Anaphylaxis Disorders.
    González de Olano D; Cain WV; Bernstein JA; Akin C
    J Allergy Clin Immunol Pract; 2023 Jul; 11(7):1989-1996. PubMed ID: 37220812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
    González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
    Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis.
    Gülen T
    Diagnostics (Basel); 2023 Oct; 13(21):. PubMed ID: 37958203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on idiopathic anaphylaxis.
    Calvani M
    Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27():52-53. PubMed ID: 35080312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.
    Castells M; Butterfield J
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1097-1106. PubMed ID: 30961835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Idiopathic mast cell activation syndrome].
    van Daele PLA; Hermans MAW; Oude Elberink JHNG; van Wijk RG
    Ned Tijdschr Geneeskd; 2022 Jan; 166():. PubMed ID: 35129899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insect Sting Anaphylaxis-Or Mastocytosis-Or Something Else?
    Golden DBK; Carter MC
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1117-1123. PubMed ID: 30961837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.